BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced its strategic plan to transition from a prescription to a non-prescription business model.

This new business model will be based on the Group's industry ... It helps its clients drive their digital transformation and obtain tangible and sustainable benefits. The Group provides end ...